2018 (v1)
Publication
No description
Uploaded on: April 14, 2023
S
G
Last name: SOCIE
First name: Gerard
No description
60-70% of AML patients have an indication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) during their treatment. Graft versus host disease (GvHD), the major cause of mortality and comorbidities post-transplantation, develops by immunological mechanism and decides greatly prognosis and quality of life (QoL) of graft recipient....